JKS [JinkoSolar] UPLOAD: (Original Filing)
[]
JOBS [51JOB] 6-K: 51JOB, INC. NOTICE OF ANNUAL GENERAL MEETING OF
[51JOB, INC. NOTICE OF ANNUAL GENERAL MEETING OF MEMBERS ORDINARY RESOLUTIONS To re-elect Mr. David K. Chao as a director of the Company. To re-elect Mr. James Jianzhang Liang as a director of the Company. To elect Mr. Kazumasa Watanabe as a director of the Company. To re-elect Mr. Rick Yan as a director of the] [51JOB, INC. Building 3 No. 1387, Zhang Dong Road Shanghai 201203 Peoples Republic of China 2012 ANNUAL GENERAL MEETING OF MEMBERS TO BE HELD ON DECEMBER 6, 2012 PROXY STATEMENT 1 / 3 % of the outstanding common shares of the Company. Members of record at the close of business on October 17, 2012 (the Record Date) of shares in] [51JOB, INC. (Incorporated in the Cayman Islands as an exempted company with limited liability) PROXY FORM AND WRITTEN CONSENT (Name) (Address) which, the person chairing the Meeting), to act as my/our proxy for the Meeting and at any adjournment or postponement thereof and to vote all of my/our Shares on my/our behalf as directed below. Please indicate with an X] [EX-99.4 5 d426253dex994.htm EX-99.4] [51job, Inc. is furnishing under the cover of Form 6-K: 99.1 Notice of Annual General Meeting of Members of 51job, Inc. dated October 23, 2012 99.2 Proxy Statement for Annual General Meeting of Members of 51job, Inc. 99.3 Form of Proxy Form and Written Consent for Holders of Common Shares 99.4 Form of Voting Instruction Card to JPMorgan Chase Bank]
TPI [TIANYIN PHARMACEUTICAL] CORRESP: (Original Filing)
[October 23, 2012 Division of Corporate Finance 100 F. Street, N.E. Attn: Nandini Acharya Re: Tianyin Pharmaceutical Co., Inc. Dear Ms. Acharya: This letter is provided in response to your letters dated April 5, 2012 and June 27, 2012, regarding the above-referenced Post Effective Amendments to Form S-1 for Tianyin Pharmaceutical Co., Inc. (the “Company”). Responses are set forth below]
TPI [TIANYIN PHARMACEUTICAL] CORRESP: October 23, 2012 Division of Corporate Finance 100
[October 23, 2012 Division of Corporate Finance 100 F. Street, N.E. Attn: Nandini Acharya Re: Tianyin Pharmaceutical Co., Inc. Dear Ms. Acharya: This letter is provided in response to your letters dated April 5, 2012 and June 27, 2012, regarding the above-referenced Post Effective Amendments to Form S-1 for Tianyin Pharmaceutical Co., Inc. (the “Company”). Responses are set forth below]
TPI [TIANYIN PHARMACEUTICAL] POS AM: (Original Filing)
[Post Effective Amendment No.3 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 20-4857782 (I.R.S. Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 Renmin Road South, Chengdu, P. R. China, 610041 +0086-28-86154737 Dr. Guoqing Jiang Chief Executive Officer Tianyin Pharmaceutical Co.,] [HUNTER TAUBMAN WEISS LLP 17 State Street, Suite 2000 New York, New York 10007 (212) 732-7184 Fax: (212) 202-6380 E-mail: LTaubman@htwlaw.com October 23, 2012 Tianyin Pharmaceutical Co., Inc. 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 Ladies and Gentlemen: In so acting, we have examined and relied upon the originals or] [Patrizio & Zhao, LLC Certified Public Accountants and Consultants 322 Route 46 West Parsippany, NJ 07054 Fax: (973) 882-0788 www.pzcpa.com Member of Alliance of worldwide accounting firms CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in the Post-Effective Amendment No. 3 to a Registration Statement on Form S-1 pertaining to the registration of 15,784,640 shares of]
TPI [TIANYIN PHARMACEUTICAL] POS AM: Post Effective Amendment No.3 to FORM S-1 REGISTRATION
[Post Effective Amendment No.3 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 20-4857782 (I.R.S. Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 Renmin Road South, Chengdu, P. R. China, 610041 +0086-28-86154737 Dr. Guoqing Jiang Chief Executive Officer Tianyin Pharmaceutical Co.,] [HUNTER TAUBMAN WEISS LLP 17 State Street, Suite 2000 New York, New York 10007 (212) 732-7184 Fax: (212) 202-6380 E-mail: LTaubman@htwlaw.com October 23, 2012 Tianyin Pharmaceutical Co., Inc. 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 Ladies and Gentlemen: In so acting, we have examined and relied upon the originals or] [Patrizio & Zhao, LLC Certified Public Accountants and Consultants 322 Route 46 West Parsippany, NJ 07054 Fax: (973) 882-0788 www.pzcpa.com Member of Alliance of worldwide accounting firms CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in the Post-Effective Amendment No. 3 to a Registration Statement on Form S-1 pertaining to the registration of 15,784,640 shares of]
